HemCon Medical Technologies Inc. on Tuesday announced the addition of a new anti-hemorrhage bandage to its product list.

ChitoGauze, designed for battlefield and acute care use, received U.S. Food and Drug Administration clearance in April, and is available for the military medical market in a 4-inch-by-4-yard gauze dressing.

The new product joins the HemCon Bandage, which are both used to stop hemorrhage and severe bleeding. Both use chitosan, a shrimp-derived molecule that aids with blood clotting.

Portland-based biotech company HemCon has operations in Ireland, England, Germany and the Czech Republic.

The full article is available on the Portland Business Journal's Web Site